| CAS ID: | 18559-94-9 |
| Molecular Formula: | C13H21NO3 |
| Molecular Weight: | 239.3 g/mol |
| Monoisotopic Mass: | 239.1521 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | PROAIR HFA | COMBIVENT | COBUTOLIN | VENTMAX SR | LIBETIST | SALBUTAMOL SULFATE | PROAIR RESPICLICK | VENTOLIN CR | Accuneb | ASMAVENT | ASMASAL SPACEHALER | AIROMIR | VOSPIRE ER | SCH 13949W SULFATE | Ventolin HFA | VOLMAX | SALIPRANEB | SALBULIN NOVOLIZER | RIMASAL | PROVENTIL-HFA | PROVENTIL | KENTAMOL | Duoneb | ASMASAL CLICKHALER | VENTOLIN HFA | ACCUNEB | STERI-NEB SALAMOL | SALBUTAMOL | SALAPIN | IPRAMOL STERI-NEB | VENTOLIN ROTACAPS | SCH-13949W | VENTOLIN E-BREATHE | Proventil HFA | Proair HFA | MAXIVENT | ALBUTEROL | AEROLIN | VENTODISKS | SALBUVENT | ASMAVEN | PROAIR | ALBUTEROL SULFATE | VENTOLIN | SALAMOL E-BREATHE | AEROLIN AUTO | AEROLIN 400 | COMBIVENT UDVS | AIRSALB |
| Analysis: | Drug repositioning mechanism analysis |
Trial Record 1
| ClinicalTrial ID | NCT01880723 | Disease | Cystic fibrosis |
| Phase | Not Applicable | Status | Completed |
| First Received | June 19, 2013 | Last Verified | June 25, 2014 |
| Sponsor | University of Arizona | ||
Trial Record 2
| ClinicalTrial ID | NCT00005110 | Disease | Cystic fibrosis |
| Phase | Not Applicable | Status | Suspended |
| First Received | April 14, 2000 | Last Verified | June 24, 2005 |
| Sponsor | National Center for Research Resources (NCRR) | ||
Trial Record 3
| ClinicalTrial ID | NCT01457261 | Disease | Idiopathic pulmonary fibrosis |
| Phase | Phase 1 | Status | Completed |
| First Received | October 21, 2011 | Last Verified | November 5, 2014 |
| Sponsor | Royal Brompton & Harefield NHS Foundation Trust | ||